These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8330429)

  • 1. An attempt at real prophylaxis of primary dysmenorrhea: comparison between meclofenamate sodium and naproxen sodium.
    Benassi L; Bertani D; Avanzini A
    Clin Exp Obstet Gynecol; 1993; 20(2):102-7. PubMed ID: 8330429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naproxen, paracetamol and pamabrom versus paracetamol, pyrilamine and pamabrom in primary dysmenorrhea: a randomized, double-blind clinical trial.
    Ortiz MI; Murguía-Cánovas G; Vargas-López LC; Silva R; González-de la Parra M
    Medwave; 2016 Oct; 16(9):e6587. PubMed ID: 27813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
    Chan WY; Fuchs F; Powell AM
    Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.
    Daniels SE; Torri S; Desjardins PJ
    J Gen Intern Med; 2005 Jan; 20(1):62-7. PubMed ID: 15693930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative.
    Lundström V
    Acta Obstet Gynecol Scand; 1978; 57(5):421-8. PubMed ID: 103358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysmenorrhea in women with intrauterine contraceptive device. Treatment with a prostaglandin synthetase inhibitor, naproxen.
    Lalos O; Nilsson B
    Int J Gynaecol Obstet; 1983 Feb; 21(1):33-7. PubMed ID: 6133791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.
    Hanson FW; Izu A; Henzl MR
    Obstet Gynecol; 1978 Nov; 52(5):583-7. PubMed ID: 364357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naproxen in the treatment of OC-resistant primary dysmenorrhea. A double-blind cross-over study.
    Jacobson J; Lundström V; Nilsson B
    Acta Obstet Gynecol Scand Suppl; 1983; 113():87-9. PubMed ID: 6407271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant, long-lasting pain relief in primary dysmenorrhea with low-dose naproxen sodium compared with acetaminophen: a double-blind, randomized, single-dose, crossover study.
    Daniels SE; Paredes-Diaz A; An R; Centofanti R; Tajaddini A
    Curr Med Res Opin; 2019 Dec; 35(12):2139-2147. PubMed ID: 31397597
    [No Abstract]   [Full Text] [Related]  

  • 11. Diflunisal compared with naproxen in the treatment of dysmenorrhea.
    Kajanoja P; Kauste K
    Prostaglandins Leukot Med; 1984 Aug; 15(2):153-8. PubMed ID: 6387717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meclofenamate sodium, phenylbutazone, and naproxen in the treatment of degenerative joint disease. Report of a placebo-controlled double-blind clinical comparison.
    López Sánchez J; Yañez Marchena G
    Arzneimittelforschung; 1983; 33(4A):653-6. PubMed ID: 6349651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of meclofenamic acid in the treatment of lesions deriving from minor traumatology.
    Vecchiet L; Colozzi A
    Clin J Pain; 1991; 7 Suppl 1():S54-9. PubMed ID: 1810522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous objective and subjective evaluation of meclofenamate sodium in the treatment of primary dysmenorrhea.
    Smith RP; Powell JR
    Am J Obstet Gynecol; 1987 Sep; 157(3):611-8. PubMed ID: 3307421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naproxen sodium, aspirin, and placebo in primary dysmenorrhea. Reduction of pain and blood levels of prostaglandin F2-alpha metabolite.
    Rosenwaks Z; Jones GS; Henzl MR; Dubin NH; Ghodgaonkar RB; Hoffman S
    Am J Obstet Gynecol; 1981 Jul; 140(5):592-8. PubMed ID: 7246695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe, primary dysmenorrhea treated with naproxen. A prospective, double-blind, crossover investigation.
    Hamann GO
    Prostaglandins; 1980 May; 19(5):651-7. PubMed ID: 6448429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valdecoxib, a cyclooxygenase-2-specific inhibitor, is effective in treating primary dysmenorrhea.
    Daniels SE; Talwalker S; Torri S; Snabes MC; Recker DP; Verburg KM
    Obstet Gynecol; 2002 Aug; 100(2):350-8. PubMed ID: 12151162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea: satisfaction, productivity, and functional disability outcomes.
    Cady RK; Diamond ML; Diamond MP; Ballard JE; Lener ME; Dorner DP; Derosier FJ; McDonald SA; White J; Runken MC
    Headache; 2011 May; 51(5):664-73. PubMed ID: 21521204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
    Allais G; Castagnoli Gabellari I; Rolando S; Benedetto C
    Expert Rev Neurother; 2011 Oct; 11(10):1383-7. PubMed ID: 21955195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies.
    Milsom I; Minic M; Dawood MY; Akin MD; Spann J; Niland NF; Squire RA
    Clin Ther; 2002 Sep; 24(9):1384-400. PubMed ID: 12380631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.